2026 is shaping up to be a pivotal year for health care reimbursement.
From major CMS payment rules to evolving disclosure requirements, AI scrutiny, and mounting pressure on providers across the care continuum, the 2026...more
1/22/2026
/ Centers for Medicare & Medicaid Services (CMS) ,
Disclosure Requirements ,
Enforcement Actions ,
Enrollment ,
Guidance Update ,
Health Care Providers ,
Health Insurance ,
Healthcare Facilities ,
Home Health Care ,
Hospice ,
Hospitals ,
Medical Devices ,
Medical Equipment ,
Medical Reimbursement ,
Medicare ,
PECOS ,
Physician Fee Schedule ,
Physicians ,
Price Transparency ,
Regulatory Oversight ,
Regulatory Requirements ,
Reimbursements ,
Revocation ,
Rural Health Care Providers
Clients & Friends,
Welcome to the second edition of our newsletter. The response to our inaugural issue reinforced what we already knew to be true: the life sciences community thrives on active dialogue. As we move deeper...more
9/15/2025
/ Biologics ,
Brand ,
Cybersecurity ,
Hatch-Waxman ,
Imports ,
Intellectual Property Protection ,
International Trade ,
Life Sciences ,
Medical Devices ,
New Regulations ,
Patents ,
PFAS ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Regulatory Requirements ,
Risk Management ,
Supply Chain ,
Tariffs ,
US Trade Policies